@techreport{FDA-RWE,
   author = {FDA},
   title = {Framework for FDAâ€™s Real-World Evidence Program},
   year = {December 2018},
   type = {Report}
}

@article{wang2021start,
  title={STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies},
  author={Wang, Shirley V and Pinheiro, Simone and Hua, Wei and Arlett, Peter and Uyama, Yoshiaki and Berlin, Jesse A and Bartels, Dorothee B and Kahler, Kristijan H and Bessette, Lily G and Schneeweiss, Sebastian},
  journal={bmj},
  volume={372},
  year={2021},
  publisher={British Medical Journal Publishing Group}
}

@article{hernan2016target,
  title={Using big data to emulate a target trial when a randomized trial is not available},
  author={Hern{\'a}n, Miguel A and Robins, James M},
  journal={American journal of epidemiology},
  volume={183},
  number={8},
  pages={758--764},
  year={2016},
  publisher={Oxford University Press}
}

@article{purpura2022role,
  title={The role of real-world evidence in FDA-approved new drug and biologics license applications},
  author={Purpura, Christina A and Garry, Elizabeth M and Honig, Nicholaas and Case, Abigail and Rassen, Jeremy A},
  journal={Clinical Pharmacology \& Therapeutics},
  volume={111},
  number={1},
  pages={135--144},
  year={2022},
  publisher={Wiley Online Library}
}

